125 related articles for article (PubMed ID: 32917663)
1. Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival-A Nationwide Cohort Study from Finland.
Santala EEE; Murto MO; Artama M; Pukkala E; Visvanathan K; Murtola TJ
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2376-2382. PubMed ID: 32917663
[TBL] [Abstract][Full Text] [Related]
2. Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland.
Santala EEE; Kotsar A; Veitonmäki T; Tammela TLJ; Murtola TJ
Scand J Urol; 2019 Aug; 53(4):185-192. PubMed ID: 31250699
[No Abstract] [Full Text] [Related]
3. Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland-A nationwide cohort study.
Santala EE; Rannikko A; Murtola TJ
Int J Cancer; 2019 Feb; 144(3):440-447. PubMed ID: 30110124
[TBL] [Abstract][Full Text] [Related]
4. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
6. Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs).
Hsieh MS; How CK; Hsieh VC; Chen PC
Shock; 2020 Apr; 53(4):407-415. PubMed ID: 31135703
[TBL] [Abstract][Full Text] [Related]
7. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
8. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Pérez-Gómez B; Lope V; Tusquets I; Alonso MH; Moreno V; Amiano P; Molina de la Torre AJ; Barricarte A; Tardon A; Camacho A; Peiro-Perez R; Marcos-Gragera R; Muñoz M; Michelena-Echeveste MJ; Ortega Valin L; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
PLoS One; 2016; 11(8):e0159672. PubMed ID: 27508297
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulants and Breast Cancer Survival: A Nationwide Cohort Study.
Kinnunen PT; Murto MO; Artama M; Pukkala E; Visvanathan K; Murtola TJ
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):208-215. PubMed ID: 31653681
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: impact of drug class on adherence to antihypertensives.
Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
[TBL] [Abstract][Full Text] [Related]
13. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.
Raimondi S; Botteri E; Munzone E; Cipolla C; Rotmensz N; DeCensi A; Gandini S
Int J Cancer; 2016 Jul; 139(1):212-9. PubMed ID: 26916107
[TBL] [Abstract][Full Text] [Related]
14. Improved renal cancer prognosis among users of drugs targeting renin-angiotensin system.
Eskelinen T; Veitonmäki T; Kotsar A; Tammela TLJ; Pöyhönen A; Murtola TJ
Cancer Causes Control; 2022 Feb; 33(2):313-320. PubMed ID: 34921656
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study.
Ferreira JP; Couchoud C; Gregson J; Tiple A; Glowacki F; London G; Agarwal R; Rossignol P
Nephrol Dial Transplant; 2019 Jul; 34(7):1216-1222. PubMed ID: 30590716
[TBL] [Abstract][Full Text] [Related]
16. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study.
Rasmussen ER; Pottegård A; Bygum A; von Buchwald C; Homøe P; Hallas J
J Intern Med; 2019 May; 285(5):553-561. PubMed ID: 30618189
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
20. Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies.
Zhao Y; Wang Q; Zhao X; Meng H; Yu J
Clin Exp Hypertens; 2018; 40(1):22-27. PubMed ID: 29115847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
